Background
Methods and materials
Study design
TMD diagnosis and subtypes/categories
Statistical analyses
Results
Variables | All patients | Before COVID | During COVID |
P-value
|
---|---|---|---|---|
Number of TMD patients
| ||||
n (%)
| 838 (100) | 367 (100) | 471 (100) | |
Sex
| ||||
Female, n (%)
| 626 (74.7) | 276 (75.2) | 350 (74.3) | 0.768 |
Male, n (%)
| 212 (25.3) | 91 (24.8) | 121 (25.7) | |
Female;male ratio
| 3.0 | 3.0 | 2.9 | |
Age
| ||||
Mean (SD)
| 32.10 (15.52) | 30.86 (14.77) | 33.07 (16.02) | 0.082^ |
Median (IQR)
| 27.00 (18.00) | 27.00 (15.00) | 28.00 (19.00) | |
Age groups, n (%) | ||||
Adolescents/young adults | 673 (80.3) | 304 (82.8) | 369 (78.3) | 0.105 |
Middle-aged/older adults | 165 (19.7) | 63 (17.2) | 102 (21.7) | |
TMD duration (months)
| ||||
Mean (SD)
| 16.80 (37.12) | 17.48 (39.89) | 16.27 (34.85) | 0.520^ |
Median (IQR)
| 3.00 (11.50) | 3.00 (11.50) | 3.00 (11.33) |
Variables | All patients | Before COVID (BC) | During COVID (DC) |
P-value
|
---|---|---|---|---|
Total
| ||||
n (%) | 838 (100) | 367 (100) | 471 (100) | |
Pain-related TMDs (PT)
| ||||
Arthralgia
| 374 (44.6) | 161 (43.9) | 213 (45.2) | 0.696* |
Myalgia
| 197 (23.5) | 60 (16.3) | 137 (29.1) |
< 0.001*
DC > BC |
Local myalgia
| 118 (14.1) | 32 (8.7) | 86 (18.3) |
< 0.001*
DC > BC |
Myofascial pain
| 67 (8.0) | 27 (7.4) | 40 (8.5) | 0.548* |
Myofascial pain with referral
| 6 (0.7) | 1 (0.3) | 5 (1.1) | 0.239* |
Headache attributed to TMDs
| 51 (6.1) | 14 (3.8) | 37 (7.9) |
0.015*
DC > BC |
Number of PT conditions
| ||||
Mean (SD)
| 0.74 (0.78) | 0.64 (0.71) | 0.82 (0.83) |
0.002^
DC > BC |
Median (IQR)
| 1.00 (1.00) | 1.00 (1.00) | 1.00 (1.00) | |
Intra-articular TMDs (IT)
| ||||
Disc displacements (DD)
| 609 (72.7) | 272 (74.1) | 337 (71.6) | 0.409* |
Disc displacement with reduction (DDwR)
| 311 (37.1) | 132 (36.0) | 179 (38.0) | 0.545* |
DDwR
| 253 (30.2) | 107 (29.2) | 146 (31.0) | 0.564* |
DDwR with intermittent locking
| 58 (6.9) | 25 (6.8) | 33 (7.0) | 0.912* |
Disc displacement without reduction (DDw/oR)
| 298 (35.6) | 140 (38.2) | 158 (33.6) | 0.167* |
DDw/oR with limited opening
| 128 (15.3) | 56 (15.3) | 72 (15.3) | 0.991* |
DDw/oR without limited opening
| 170 (20.3) | 84 (22.9) | 86 (18.3) | 0.098* |
Degenerative joint disease
| 259 (30.9) | 89 (24.3) | 170 (36.1) |
< 0.001*
DC > BC |
Subluxation | 14 (1.7) | 5 (1.4) | 9 (1.9) | 0.539* |
Number of IT conditions
| ||||
Mean (SD)
| 1.05 (0.56) | 1.00 (0.49) | 1.08 (0.61) |
0.022^
DC > BC |
Median (IQR)
| 1.00 (0) | 1.00 (0) | 1.00 (0) | |
Total number of TMD conditions
| ||||
Mean (SD)
| 1.79 (0.91) | 1.64 (0.80) | 1.91 (0.97) |
< 0.001^
DC > BC |
Median (IQR)
| 2.00 (1.00) | 1.00 (1.00) | 2.00 (2.00) | |
TMD categories
| ||||
Pain-related, n (%)
| 113 (13.5) | 45 (12.3) | 68 (14.4) | 0.360* |
Intra-articular, n (%)
| 363 (43.3) | 173 (47.1) | 190 (40.3) |
0.049*
BC > DC |
Combined n (%)
| 362 (43.2) | 149 (40.6) | 213 (45.2) | 0.180* |
Females (F) | Males (M) | Between sexes | ||||||
---|---|---|---|---|---|---|---|---|
Variables | Before COVID (BC) | During COVID (DC) |
P-value
| Before COVID (BC) | During COVID (DC) |
P-value
| Before COVID
P-value
| During COVID
P-value
|
Number of pain-related conditions
| ||||||||
Mean (SD)
| 0.64 (0.69) | 0.82 (0.85) |
0.024^
DC > BC | 0.63 (0.78) | 0.82 (0.76) |
0.030^
DC > BC | 0.478^ | 0.775^ |
Median (IQR)
| 1.00 (1.00) | 1.00 (1.00) | 0 (1.00) | 1.00 (1.00) | ||||
Number of intra-articular conditions
| ||||||||
Mean (SD)
| 1.02 (0.47) | 1.14 (0.58) |
0.003^
DC > BC | 0.93 (0.55) | 0.92 (0.67) | 0.729^ | 0.158^ |
< 0.001^
F > M |
Median (IQR)
| 1.00 (0) | 1.00 (0.25) | 1.00 (0) | 1.00 (1.00) | ||||
Total number of TMD conditions
| ||||||||
Mean (SD)
| 1.66 (0.79) | 1.97 (0.99) |
< 0.001^
DC > BC | 1.56 (0.83) | 1.74 (0.88) | 0.116^ | 0.132^ |
0.028^
F > M |
Median (IQR)
| 1.50 (1.00) | 2.00 (1.00) | 1.00 (1.00) | 1.00 (1.00) | ||||
TMD categories
| ||||||||
Pain-related, n (%)
| 28 (10.1) | 37 (10.6) | 0.862* | 17 (18.7) | 31 (25.6) | 0.232* |
0.017*
M > F |
< 0.001*
M > F |
Intra-articular, n (%)
| 126 (45.7) | 146 (41.7) | 0.324* | 47 (51.6) | 44 (36.4) |
0.026*
BC > DC |
0.017*
M > F |
< 0.001*
F > M |
Combined, n (%)
| 122 (44.2) | 167 (47.7) | 0.382* | 27 (29.7) | 46 (38.0) | 0.206* |
0.017*
F > M |
< 0.001*
F > M |
Adolescents/young adults (AY) | Middle-aged/older adults (MO) | Between age groups | |||||||
---|---|---|---|---|---|---|---|---|---|
Variables | Before COVID (BC) | During COVID (DC) |
P-value
| Before COVID (BC) | During COVID (DC) |
P-value
| Before COVID
P-value
| During COVID
P-value
| |
Number of pain-related conditions
| |||||||||
Mean (SD)
| 0.57 (0.70) | 0.68 (0.79) | 0.112^ | 0.98 (0.68) | 1.32 (0.75) |
0.004^
DC > BC |
< 0.001^
MO > AY |
< 0.001^
MO > AY | |
Median (IQR)
| 0 (1.00) | 1.00 (1.00) | 1.00 (0) | 1.00 (1.00) | |||||
Number of intra-articular conditions
| |||||||||
Mean (SD)
| 1.02 (0.47) | 1.11 (0.57) |
0.026^
DC > BC | 0.89 (0.60) | 1.00 (0.73) | 0.332^ | 0.055^ | 0.158^ | |
Median (IQR)
| 1.00 (0) | 1.00 (0) | 1.00 (0) | 1.00 (2.00) | |||||
Total number of TMD conditions
| |||||||||
Mean (SD)
| 1.59 (0.76) | 1.79 (0.89) |
0.005^
DC > BC | 1.87 (0.92) | 2.32 (1.12) |
0.011^
DC > BC |
0.017^
MO > AY | < 0.001^ MO > AY | |
Median (IQR)
| 1.00 (1.00) | 2.00 (1.00) | 2.00 (1.00) | 2.00 (2.00) | |||||
TMD categories
| |||||||||
Pain-related, n (%)
| 30 (9.9) | 41 (11.1) | 0.601* | 15 (23.8) | 27 (26.5) | 0.703* |
< 0.001
*
MO > AY |
< 0.001
*
MO > AY | |
Intra-articular, n (%)
| 160 (52.6) | 183 (49.6) | 0.433* | 13 (20.6) | 7 (6.9) |
0.008*
BC > DC |
< 0.001
*
AY > MO |
< 0.001
*
AY > MO | |
Combined, n (%)
| 114 (37.5) | 145 (39.3) | 0.634* | 35 (55.6) | 68 (66.7) | 0.152* |
< 0.001
*
MO > AY |
< 0.001
*
MO > AY |
Univariate | Multivariate | |||
---|---|---|---|---|
Variables | Odds ratio (95% CI) | P-value* | Odds ratio (95% CI) | P-value^ |
Painful TMDs
| ||||
Pandemic
| ||||
Before COVID | Reference |
-
| Reference | - |
During COVID
| 1.21 (0.81–1.81) | 0.361 | - | |
Sex
| ||||
Female
| 2.53 (1.67–3.81) |
< 0.001
| 2.52 (1.65–3.86) |
< 0.001
|
Male
| Reference | Reference | ||
Age
| 1.04 (1.02–1.05) |
< 0.001
| 1.04 (1.02–1.05) |
< 0.001
|
Sex*age
| ||||
Female*age
| - |
-
| ||
Male*age
| Reference | - | ||
Intra-articular TMDs
| ||||
Pandemic
| ||||
Before COVID | Reference | - | Reference | - |
During COVID
| 0.76 (0.58-1.00) |
0.049
| - | - |
Sex
| ||||
Female
| 0.98 (0.72–1.34) | 0.894 | - | - |
Male
| Reference | Reference- | - | |
Age
| 0.95 (0.93–0.96) |
< 0.001
| 0.95 (0.93–0.96) |
< 0.001
|
Sex*age
| ||||
Female*age
| - | - | ||
Male*age
| Reference- | - | ||
Combined TMDs
| ||||
Pandemic
| ||||
Before COVID | Reference | Reference | - | |
During COVID
| 1.21 (0.92–1.59) | 0.180 | - | - |
Sex
| ||||
Female
| 1.63 (1.18–2.26) |
0.003
| - | - |
Male
| Reference | Reference | ||
Age
| 1.03 (1.02–1.04) |
< 0.001
| 1.02 (1.01–1.03) |
0.003
|
Sex*age
| ||||
Female*age
| 1.02 (1.01–1.02) |
0.001
| ||
Male*age
| Reference- | - |